Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Pilot Study Evaluating the Safety, Feasibility, and Preliminary Clinical Activity of Inhaled Cromolyn Sodium in Participants With Locally Advanced Lung Cancer

NCT07675876 is registered in ClinicalTrials.gov with Carcinex Inc as lead sponsor.

NCT NCT07675876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07675876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Pilot Study Evaluating the Safety, Feasibility, and Preliminary Clinical Activity of Inhaled Cromolyn Sodium in Participants With Locally Advanced Lung Cancer
Lead sponsor
Carcinex Inc
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2027
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced non-small cell lung cancer, lung adenocarcinoma